Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors
NCT03627299
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
11
Enrollment
OTHER
Sponsor class
Conditions
End Stage Renal Disease
Hepatitis C
Interventions
DRUG:
300mg glecaprevir/pibrentasivir 120mg
Sponsor
Johns Hopkins University